Concepedia

D. Lanser

DL

Statistics

Publications

3

Citations

66

H-Index

3

Active since

2022

Affiliations

Erasmus MC Cancer Institute(Current)

Erasmus MC

D. Lanser is an author at Erasmus MC Cancer Institute specializing in cancer pharmacology, pharmacy, and oncology.

ORCID

Publications per year

2022–2023

3

Publications

3

Improving the tolerability of osimertinib by identifying its toxic limit

Bram C. Agema, G. Veerman, C. Steendam et al. · Therapeutic Advances in Medical Oncology · 2022 · 41 citations · Full text

, , +17

Influence of Food With Different Fat Concentrations on Alectinib Exposure: A Randomized Crossover Pharmacokinetic Trial

D. Lanser, Simon P. de Leeuw, Esther Oomen‐de Hoop et al. · Journal of the National Comprehensive Cancer Network · 2023 · 13 citations · Full text

, , +17

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients

D. Lanser, Maud B. A. van der Kleij, G. Veerman et al. · Biomedicine & Pharmacotherapy · 2023 · 12 citations · Full text

, , +17

1–3 of 3